Related Experiment Video
Updated: Mar 3, 2026
13:23
Selecting and Isolating Colonies of Human Induced Pluripotent Stem Cells Reprogrammed from Adult Fibroblasts
Published on: February 20, 2012
20.5K
Pharmacological Reprogramming of Somatic Cells for Regenerative Medicine
Min Xie1, Shibing Tang1, Ke Li1
1Gladstone Institutes , 1650 Owens Street, San Francisco, California 94158, United States.
Accounts of Chemical Research
|April 29, 2017
Summary
Researchers developed pharmacological methods to reprogram somatic cells into induced pluripotent stem cells (iPSCs) and other cell types. These chemical approaches enhance cell reprogramming for regenerative medicine and therapeutic transplantation.
Area of Science:
- Regenerative Medicine
- Cellular Reprogramming
- Pharmacological Biology
Background:
- Cellular therapies require methods to generate sufficient numbers of specific cell types for transplantation.
- Induced pluripotent stem cells (iPSCs) offer a source of renewable cells for regenerative medicine.
- Genetic methods for cell reprogramming can be enhanced or replaced by pharmacological agents.
Purpose of the Study:
- To identify and develop small molecules and chemical cocktails for efficient cellular reprogramming.
- To establish a general strategy for developing pharmacological reprogramming cocktails.
- To explore alternative chemical strategies for cell transdifferentiation.
Main Methods:
- Screening of chemical libraries to identify small molecules enhancing transcription factor-mediated pluripotency induction.
- Development of small molecule cocktails to replace transcription factors for pluripotency induction.
- Establishment of a cell-activation and signaling-directed (CASD) transdifferentiation paradigm using chemical treatments.
Main Results:
- Identified small molecules that enhance pluripotency induction and developed cocktails that functionally replace transcription factors.
- Devised a general strategy for creating effective pharmacological reprogramming cocktails.
- Demonstrated CASD transdifferentiation to convert fibroblasts into various somatic cells (cardiac, neural, liver, pancreas) without genetic manipulation, showing therapeutic benefits in animal models.
Conclusions:
- Pharmacological reprogramming offers a powerful, non-genetic approach to generate diverse cell types for regenerative medicine.
- Advanced chemical tools significantly enhance cellular reprogramming efficiency and cell quality for clinical applications.
- These chemical reprogramming strategies hold great promise for future transplantation therapies and treating organ damage.
More Related Videos
10:52Isolation of Adult Human Dermal Fibroblasts from Abdominal Skin and Generation of Induced Pluripotent Stem Cells Using a Non-Integrating Method
Published on: January 19, 2020
11.4K
12:12In vivo Reprogramming of Adult Somatic Cells to Pluripotency by Overexpression of Yamanaka Factors
Published on: December 17, 2013
13.1K
Related Concept Videos
01:29Somatic to iPS Cell Reprogramming
2.7K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.7K
01:24Methods of Nuclear Reprogramming
2.2K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.2K
01:14Introduction to Nuclear Reprogramming
2.4K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
2.4K
01:06Induced Pluripotent Stem Cells
5.7K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.7K
01:13Induced Pluripotent Stem Cells
28.2K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.2K
01:22iPS Cell Differentiation
3.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.2K